Loading...
Loading...
For employees of late-stage private companies, the question of how to sell pre-IPO shares is no longer reserved for executives or early investors. The median time from founding to IPO has stretched past eleven years, and many employees today hold equity that is theoretically worth six or seven figures yet impossible to spend, save, or diversify against. Understanding the mechanics, tradeoffs, and tax consequences of selling shares before IPO has become a core financial planning skill, not an edge case.
This guide walks through the practical steps, the legal and tax considerations, and the common pitfalls that catch even seasoned operators off guard. In my experience over the last fifteen years on the venture side, employees often discover too late that paper wealth and real wealth are very different things — and that selling shares before IPO is rarely a single decision but a sequence of small, technical ones.
Two structural shifts explain the rise of pre-IPO secondary sale activity. First, companies are staying private longer; reporting from Bloomberg and other outlets has documented how the share of late-stage capital raised in private rounds rather than public ones has shifted dramatically over the last decade. Second, post-termination exercise windows mean employees who leave a company often have only ninety days to either buy their options at potentially eye-watering strike prices and 409A spreads or forfeit them entirely.
Add concentrated risk — most employees have a meaningful percentage of their net worth tied to a single private stock — and the appeal of even a partial pre-IPO secondary sale becomes obvious. As the Aption team has discussed in The Problem for Stock & Option Holders, the structural mismatch between illiquid equity and life expenses (down payments, tuition, retirement) is a genuine financial problem rather than a luxury concern.
Before walking through how to sell pre-IPO shares mechanically, it helps to know the menu. There are five common paths, each with different liquidity, fee, and tax profiles:
The right answer depends on company policy, your liquidity needs, your tax situation, and your willingness to remain exposed to the underlying company after a transaction closes.
When clients ask me how to sell pre-IPO shares without making expensive mistakes, I walk them through six steps. None of them are glamorous, but skipping any of them is where most preventable losses happen.
Step 1 — Confirm what you actually own. Pull your option grant documents, your latest 409A valuation, your vesting schedule, and your stockholder agreement. Distinguish between exercised shares (which you own outright), unexercised options (which you do not), and RSUs (which typically only settle on a defined liquidity event). Only exercised shares are sellable in most secondary contexts.
Step 2 — Read your stockholder and option agreements carefully. Most private company shareholder agreements include transfer restrictions, ROFR clauses giving the company the right to match any third-party offer, co-sale rights, and sometimes outright bans on transfers without board approval. The U.S. Securities and Exchange Commission maintains guidance on Rule 144 and private resales that is required reading before any secondary sale; failing to comply with these rules can void a transaction or create personal liability.
Step 3 — Get a current valuation reference. A 409A valuation is set for tax purposes and is usually conservative. The market price for your shares in a private secondary may be higher (in hot names) or meaningfully lower (in distressed or down-round situations). Look at recent funding rounds, secondary marketplace bids, and tender prices if available. For a more rigorous self-check on outcome ranges, the Aption Equity Simulator lets you model various exit scenarios for your specific position.
Step 4 — Decide how much to sell. This is the step most people skip. Selling 100% of your vested shares before IPO is rarely optimal: you give up upside and may trigger heavy short-term capital gains. Selling 0% leaves you exposed to total loss in a category where roughly three quarters of venture-backed companies fail to return capital. A common framework is to monetize enough to (a) cover your option exercise costs, (b) pay any AMT or income tax already due, and (c) extract a de-risking tranche representing perhaps 20–40% of your position. The right number is personal.
Step 5 — Choose a path and counter-party. Tender offers are the cleanest legally because the company runs the process. Direct secondary sales require company consent and a sophisticated buyer. Secondary marketplaces broaden the buyer pool but charge fees of roughly 3–5% per side and may take weeks to close. Equity pooling, covered below, is a different beast: you don't sell, you exchange concentration for diversification.
Step 6 — Execute, document, and report. Once a transaction closes, retain all documentation, file any required Section 83(b) elections (where applicable), and report the sale on your tax return. The Internal Revenue Service treats the gain on sale of stock based on holding period and option type — short-term versus long-term capital gains rules apply, and ISO disqualifying dispositions can convert favorable capital gains into ordinary income.
Tax treatment is where many secondary transactions go sideways. Selling shares before IPO can trigger any combination of the following:
I have seen too many employees triumphantly close a pre-IPO secondary sale only to learn six months later that their effective tax rate is north of 50%. Talk to a CPA who has handled startup equity before any signing date — not after.
A handful of traps come up repeatedly in my conversations with employees and founders:
For a deeper dive on the option side specifically, Should I Buy My Equity? walks through the buy-versus-walk-away decision tree in more detail.
There is a reason platforms like Aption have grown alongside the traditional secondary market. A pre-IPO secondary sale converts concentrated stock into cash, but it also closes the door on upside. Equity pooling instead exchanges shares for a proportional claim on a diversified pool of pre-IPO companies — preserving exposure to startup-style returns while reducing single-name risk.
Pooling is not a replacement for tender offers or marketplaces; it is a different tool with a different objective. The best approach for many employees is a blend: monetize a small portion through a tender or marketplace to cover taxes and de-risk, pool another portion to diversify, and retain a remaining slice for direct upside in the original name. The Introduction to Equity Pooling post explores the mechanics and economics in more depth.
Learning how to sell pre-IPO shares well — not merely legally, but in a way that respects your tax situation, your concentration risk, and the company's transfer rules — is a meaningful financial skill. The mechanics are knowable. The tradeoffs are personal. And the worst answer is usually doing nothing simply because the rules feel intimidating.
If you want to explore both selling and pooling paths against your specific position, you can request a personalized analysis from Aption's Get an Offer page or browse common questions in the FAQ. Whatever route you choose, the goal should be a position you can defend on a bad day, not just on a good one.
The author name used in this article may be a pen name or pseudonym and is used for illustrative and editorial purposes only. This article is for informational purposes only and does not constitute investment, tax, or legal advice. Past performance is not indicative of future results. Consult qualified professionals before making financial decisions.
Daniel is a former venture capital partner and startup equity strategist with over 15 years of experience advising founders, employees, and institutional investors on equity structures, liquidity events, and portfolio construction.